Revvity | PKI - Passifs Courants





Passifs Courants Changement Date
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 14.16M 2026-03
Bio Techne USD 153.28M 12.85M 2026-03
Bio-Rad Laboratories USD 917M 400M 2026-03
Bruker USD 1.36B 75.9M 2026-03
Celltrion KRW 292.71B 9.09B 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Danaher USD 7.46B 653M 2026-03
Dentsply International USD 1.21B 136M 2026-03
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
Edwards Lifesciences USD 1.41B 404.7M 2026-03
Illumina USD 1.57B 19M 2026-03
Intuitive Surgical USD 2.58B 65.1M 2026-06
IQVIA Holdings USD 8.33B 9M 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Laboratory Of America USD 2.64B 182.5M 2026-03
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Mesa Laboratories USD 54.4M 6.1M 2025-12
Mettler Toledo International USD 1.11B 89.76M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
OraSure Technologies USD 44.08M 4.29M 2026-03
Organigram Holdings CAD 88.74M 5.31M 2026-03
Ovoca Bio EUR 186K 2.26M 2025-06
Pacific Biosciences Of California USD 65.36M 7.48M 2026-03
Pharma Mar EUR 89.23M 4.65M 2026-03
Qiagen NV USD 512.14M 461.26M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Quidel USD 962.4M 3.7M 2026-03
Repligen USD 126.21M 9.62M 2026-03
Revvity USD 1.24B 92.6M 2026-03
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Waters USD 1.24B 11.8M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03